These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18158016)

  • 1. Sacral neuromodulation: cost considerations and clinical benefits.
    Aboseif SR; Kim DH; Rieder JM; Rhee EY; Menefee SA; Kaswick JR; Ree MH
    Urology; 2007 Dec; 70(6):1069-73; discussion 1073-4. PubMed ID: 18158016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study.
    van Kerrebroeck PE; van Voskuilen AC; Heesakkers JP; Lycklama á Nijholt AA; Siegel S; Jonas U; Fowler CJ; Fall M; Gajewski JB; Hassouna MM; Cappellano F; Elhilali MM; Milam DF; Das AK; Dijkema HE; van den Hombergh U
    J Urol; 2007 Nov; 178(5):2029-34. PubMed ID: 17869298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of sacral neuromodulation for symptomatic treatment of refractory urinary urge incontinence.
    Latini JM; Alipour M; Kreder KJ
    Urology; 2006 Mar; 67(3):550-3; discussion 553-4. PubMed ID: 16527577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sacral nerve neuromodulation (InterStim). Part III: Case studies.
    Rittenmeyer H
    Urol Nurs; 2008 Feb; 28(1):26-8. PubMed ID: 18335694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sacral nerve stimulation for voiding dysfunction: One institution's 11-year experience.
    Sutherland SE; Lavers A; Carlson A; Holtz C; Kesha J; Siegel SW
    Neurourol Urodyn; 2007; 26(1):19-28; discussion 36. PubMed ID: 17078071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral versus bilateral stage I neuromodulator lead placement for the treatment of refractory voiding dysfunction.
    Pham K; Guralnick ML; O'Connor RC
    Neurourol Urodyn; 2008; 27(8):779-81. PubMed ID: 18551562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medium-term experience of sacral neuromodulation by tined lead implantation.
    Van Voskuilen AC; Oerlemans DJ; Weil EH; van den Hombergh U; van Kerrebroeck PE
    BJU Int; 2007 Jan; 99(1):107-10. PubMed ID: 16956350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral caudal epidural neuromodulation for refractory urinary retention: a salvage procedure.
    Maher MG; Mourtzinos A; Zabihi N; Laiwalla UZ; Raz S; Rodríguez LV
    J Urol; 2007 Jun; 177(6):2237-40; discussion 2241. PubMed ID: 17509329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in depression and health-related quality of life after sacral nerve stimulation therapy for treatment of voiding dysfunction.
    Das AK; Carlson AM; Hull M;
    Urology; 2004 Jul; 64(1):62-8. PubMed ID: 15245937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sacral nerve stimulation for treatment of refractory urinary retention: long-term efficacy and durability.
    White WM; Dobmeyer-Dittrich C; Klein FA; Wallace LS
    Urology; 2008 Jan; 71(1):71-4. PubMed ID: 18242368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of sacral posterior neuromodulation on voiding disorders and impact on sexuality based on a single-center study].
    Ferhi K; Miaadi N; Tanneau Y; Leroi AM; Sibert L; Grise P
    Prog Urol; 2008 Mar; 18(3):160-6. PubMed ID: 18472068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian experience in sacral neuromodulation.
    Elkelini M; Hassouna MM
    Urol Clin North Am; 2005 Feb; 32(1):41-9. PubMed ID: 15698875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of sacral neuromodulation with the tined lead procedure.
    Marcelissen TA; Leong RK; de Bie RA; van Kerrebroeck PE; de Wachter SG
    J Urol; 2010 Nov; 184(5):1997-2000. PubMed ID: 20850820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction.
    Peeters K; Sahai A; De Ridder D; Van Der Aa F
    BJU Int; 2014 May; 113(5):789-94. PubMed ID: 24238278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sacral root neuromodulation in idiopathic nonobstructive chronic urinary retention.
    Shaker HS; Hassouna M
    J Urol; 1998 May; 159(5):1476-8. PubMed ID: 9554336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of sacral neuromodulation (SNM) with Interstim for fecal incontinence patients in Spain.
    Brosa M; Muñoz-Duyos A; Navarro-Luna A; Rodriguez JM; Serrano D; Gisbert R; Dziekan K; Segú JL
    Curr Med Res Opin; 2008 Mar; 24(3):907-18. PubMed ID: 18279582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing costs of urinary incontinence among female Medicare beneficiaries.
    Anger JT; Saigal CS; Madison R; Joyce G; Litwin MS;
    J Urol; 2006 Jul; 176(1):247-51; discussion 251. PubMed ID: 16753411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary results of sacral neuromodulation in 23 children.
    Humphreys MR; Vandersteen DR; Slezak JM; Hollatz P; Smith CA; Smith JE; Reinberg YE
    J Urol; 2006 Nov; 176(5):2227-31. PubMed ID: 17070300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study.
    van Voskuilen AC; Oerlemans DJ; Weil EH; de Bie RA; van Kerrebroeck PE
    Eur Urol; 2006 Feb; 49(2):366-72. PubMed ID: 16413105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.